After a down year for M&A activity in the biotech industry, 2021 is expected to see greater deal volume – and the four biotechs highlighted… Read More »Bought Out Or Standalone, These 4 Potential Biotech Takeover Targets Are Attractive Picks
When it comes to biotech stocks, the author of today’s article notes that “one of the best — and worst — things about these stocks… Read More »Avoid Biotech Regrets By Avoiding These 3 Common Mistakes
With the recent sell-off in biotech stocks, the author of today’s article advises that “this is the perfect opportunity to buy into high-growth biotech stocks… Read More »This High-Growth Small Cap Is On The Front Lines Of Developing Therapies For Potential Bio Attacks – And It’s Trading At A Discount
With one apparent cure under its belt, the biotech discussed in today’s article is now planning to leverage that success and take on a far… Read More »Now May Be The Perfect Time To Buy This Biotech “Leading The Race To Become The Future Of Medicine”
Today’s article highlights four small biotech stocks with the potential to go from little players to leaders in the space in relatively short order, including… Read More »4 Small Biotech Stocks With The Potential To Go From Little Players To Leaders
Right now in the biotech space, “some of the most exciting publicly traded…companies are capitalizing on our ever-growing ability to map and manipulate genes,” observes the… Read More »3 Gene Therapy Stocks With The Right Stuff
A company using artificial intelligence in the drug discovery and validation process and a company developing long-lasting “irreversible” drugs for the treatment of certain cancers… Read More »2 Recent Biotech IPOs That Could Be Worth A Speculative Buy
“Just like small- and micro-cap stocks, biotech’s been suffering through a slowdown. But as you’ll see in a moment, there’s no reason to panic (or… Read More »Sell In May And Go Away? Not With Biotech!
Messenger RNA (mRNA) has come to the forefront thanks to its role in the Pfizer-BioNTech and Moderna COVID-19 vaccines – and the potential for the… Read More »Who’s The MVP In mRNA?
“Alzheimer’s is the holy grail right now in neurology and diseases of the central nervous system (CNS) because as a form of rapid, non-normal dementia,… Read More »Biotech Stocks To Watch As An Effective Alzheimer’s Treatment Remains Elusive